Spain's leading drugmaker Almirall has launched a new research project, dubbed Nano4Derm, to investigate <\/p>\n
To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Please loginorsubscribe in order to continue reading. Claim a week's trial subscriptionby signing up for free today and receive our daily pharma and biotech news bulletin free of charge, forever. <\/p>\n
AlmirallDealsDermatologicalsPharmaceuticalResearchSpain <\/p>\n
Access The Pharma Letter's latest news free for 7 days <\/p>\n<\/p>\n
PLUS... you can receive the Pharma Letter headlines and news roundup email free forever <\/p>\n
Click here to take a free trial <\/p>\n
Unlimited access to The Pharma Letter site for a whole year Only 77 per month or 820 per year <\/p>\n<\/p>\n
Click here to subscribe <\/p>\n
<\/p>\n
Read the original:<\/p>\n
Almirall looks to nanotechnology to improve dermatology products - The Pharma Letter (registration)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Spain's leading drugmaker Almirall has launched a new research project, dubbed Nano4Derm, to investigate To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Continue reading